2005-2006 Report

Department of Medicine

 

College of Human Medicine

Michigan State University

 

 

 

Table of Contents

 

 

Page

Faculty Bibliography

4

Editorial Boards

15

Study Sections

16

Awards

19

Grants

22

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Faculty Bibliography: Journal Articles, Books and Chapters

January 2005 through June 2006

1.      Abela GS, Aziz K.  Cholesterol crystals cause mechanical damage to biological membranes: a proposed mechanism of plaque rupture and erosion leading to arterial thrombosis. Clin Cardiol. 2005 Sep;28(9):413-20.

2.      Abela GS, Aziz K.  Cholesterol crystals rupture biological membranes and human plaques during acute cardiovascular events--a novel insight into plaque rupture by scanning electron microscopy. Scanning. 2006 Jan-Feb;28(1):1-10.

3.      Acharya MR, Sparreboom A, Sausville EA, Conley BA, Doroshow JH, Venitz J, Figg WD.  Interspecies differences in plasma protein binding of MS-275, a novel histone deacetylase inhibitor. Cancer Chemother Pharmacol. 2006 Mar;57(3):275-81. Epub 2005 Jul 19.

4.      Aldasouqi S., Associate Editor:: The Year Book of Neurology and Neurosurgery (Pituitary), Mosby, St Louis, Missouri, USA (2001, 2002, 2005)

5.      Alzahrani AS, Mohamed G, Al Shammary A, Aldasouqi S, Abdal Salam S, Shoukri Long-term course and predictive factors of elevated serum thyroglobulin and negative diagnostic radioiodine whole body scan in differentiated thyroid cancer. J Endocrinol Invest. 2005 Jun;28(6):540-6.

6.      Ayoola AB, Brewer J, Nettleman M.  Epidemiology and prevention of unintended pregnancy in adolescents. Prim Care. 2006 Jun;33(2):391-403.

7.      Bogdan-Lovis EA, Sousa A.  The contextual influence of professional culture: Certified nurse-midwives' knowledge of and reliance on evidence-based practice. Soc Sci Med. 2005 Dec 22.

8.      Bonham VL, Warshauer-Baker E, Collins FS.  Race and ethnicity in the genome era: the complexity of the constructs. Am Psychol. 2005 Jan;60(1):9-15.

9.      Bouknight RR, Bradley CJ, Luo Z.  Correlates of return to work for breast cancer survivors. J Clin Oncol. 2006 Jan 20;24(3):345-53.

10.  Bowen JL, Clark JM, Houston TK, Levine R, Branch W, Clayton CP, Alguire P, Esham R, Boulware DW, Ferenchick G, Kern DE.  A national collaboration to disseminate skills for outpatient teaching in internal medicine: program description and preliminary evaluation. Acad Med. 2006 Feb;81(2):193-202.

11.  Breilh J, Branco Jefer C, Castelman BI, et al. with Rosenman K. Texaco and its consultants. Int J Occup Environ Health. 2005 Apr-Jun;11(2):217-20.

12.  Breilh J, et al including Rosenman KD:  Texaco and its consultants.Int J Occup Environ Health. 2005 Apr-Jun;11(2):217-20.

13.  Carreón T, Butler MA, Ruder AM, Waters MA, Davis-King KE, Calvert GM, Schulte PA, Connally B, Ward EM, Sanderson WT, Heineman EF, Mandel JS, Morton RF, Reding DJ, Rosenman KD, Talaska G, and the Brain Cancer Collaborative Study Group.  Gliomas and Farm Pesticide Exposure in Women:  The Upper Midwest Health Study.  Environmental Health Perspectives 2005; 113:546-551.

14.  Carreon T, Butler MA, Ruder AM, Waters MA, Davis-King KE, Calvert GM, Schulte PA, Connally B, Ward EM, Sanderson WT, Heineman EF, Mandel JS, Morton RF, Reding DJ, Rosenman KD, Talaska G, Cancer B.  Gliomas and farm pesticide exposure in women: the Upper Midwest Health Study.Environ Health Perspect. 2005 May;113(5):546-51.

15.  Chester DA, Hanna EA, Pickelman BG, Rosenman KD.  Asthma Death After Spraying Polyurethane Truck Bedliner.  American  Journal of Industrial Medicine 2005; 48:78-84.

16.  Chester DA, Hanna EA, Pickelman BG, Rosenman KD.  Asthma death after spraying polyurethane truck bedliner. Am J Ind Med. 2005 Jul;48(1):78-84.

17.  Cholia A, Voice R, Abela GS.  Quadricuspid aortic valve: a rare entity. Clin Cardiol. 2005 Aug;28(8):395.

18.  Conley BA.  Treatment of advanced head and neck cancer: what lessons have we learned? J Clin Oncol. 2006 Mar 1;24(7):1023-5.

19.  Conley BA, Forastiere AA, Gius D, VanWaes C.  2005. Head and Neck Cancer: 2005 Abraham J, Allegra C, eds; Bethesda Handbook of Clinical Oncology. Lippincott, Williams and Wilkins,  Baltimore.

20.  Donovan, E and Conley BA.  Cancers of the Head and Neck:  2005. In press: Chemotherapy Sourcebook.

21.  Cummings CE, Rosenman KD.  Ulcerative colitis reactivation after mercury vapor inhalation. Am J Ind Med. 2006 Jun;49(6):499-502.

22.  Dreger AD, Chase C, Sousa A, Gruppuso PA, Frader J.  Changing the nomenclature/taxonomy for intersex: a scientific and clinical rationale. J Pediatr Endocrinol Metab. 2005 Aug;18(8):729-33.

23.  Dunn, S, Corser, W, Stommel, M, Holmes-Rovner, M. Hopelessness and depression in the early recovery period after hospitalization for acute coronary syndrome. Forthcoming, Jl Cardiopul Rehab, May-Jun 2006.

24.  Dwamena FC. Pelvic Pain In Patient History: Evidence-Based Approach. Editors- Lawrence M. Tierney, Jr. and Mark C. Henderson. Lange Medical Books/MaGraw-Hill, 2005

25.  Dwamena FC, Fortin A, Smith RC. Patient-centered interview In Patient History: Evidence-Based Approach. Editors- Lawrence M. Tierney, Jr. and Mark C. Henderson. Lange Medical Books/MaGraw-Hill, 2005

26.  Elwyn G, O’Connor A, Stacey D, Volk R, Edwards A, Coulter A, Thomson R, Barratt A, Barry M, Bernstein S, Butow P, Clarke A, Entwistle V, Feldman-Stewart D, Holmes-Rovner M, Llewellyn-Thomas H, Moumjid N, Mulley A, Ruland C, Sepucha K, Sykes A, Whelan T.  Developing a quality criteria framework for patient decision aids: an online international modified Delphi consensus process.  In press 2006, BMJ

27.  Fitch BR, Sachen KL, Wilder SR, Burg MA, Lacher DW, Khalife WT, Whittam TS, Young VB.  Genetic diversity of Campylobacter sp. isolates from retail chicken products and humans with gastroenteritis in Central Michigan. J Clin Microbiol. 2005 Aug;43(8):4221-4.

28.  Flattery J, Davis L, Rosenman KD, Harrison R, Lyon-Callo S, Filios M.  The proportion of self-reported asthma associated with work in three States: California, Massachusetts, and Michigan, 2001. J Asthma. 2006 Apr;43(3):213-8.

29.  Ford ME, Havstad SL, Demers R, Cole Johnson C.  Effects of false-positive prostate cancer screening results on subsequent prostate cancer screening behavior. Cancer Epidemiol Biomarkers Prev. 2005 Jan;14(1):190-4.

30.  Fortin A, Dwamena FC, Smith RC:  Structure and Content of the Interview. In:  Novack D, Clark W, Saizow R, eds., “doc.com,” produced jointly by the American Academy on Physician and Patient and the Drexel University College of Medicine, 2005. Available from: www.physicianpatient.org

31.  Fortin A, Dwamena FC, Smith RC. Doctor-centered interview In Patient History: Evidence-Based Approach. Editors- Lawrence M. Tierney, Jr. and Mark C. Henderson. Lange Medical Books/MaGraw-Hill, 2005

32.  Garg S, Jampol LM, Lewis RA, Penner JA.  Corneal copper deposition secondary to a variant of multiple myeloma: 30-year catamnesis. Arch Ophthalmol. 2006 Jan;124(1):130-2.

33.  Goldstein FW and Stein GE.  Trimethoprim and trimethoprim-sulfamethoxazole (cotrimoxazole).  In:  Antimicrobial therapy and vaccines.  Volume II:  Antimicrobial Agents.  Second Edition.  ESun technologies, LLC.  Pittsburgh. 2005.

34.  Guo DF, Chenier I, Chan JSD, Lavoie J, Hamet P, Tremblay J, Chen XM, Wang DH, Inagami T. Development of hypertension and kidney hypertrophy in transgenic mice overexpressing ARAP1 gene in the kidney. Hypertension 2006 (in press)

35.  Gupta A, Rosenman KD.  Hypersensitivity pneumonitis due to metal working fluids: Sporadic or under reported?Am J Ind Med. 2006 Jun;49(6):423-33.

36.  Haidet P, Kelly PA, Bentley S, Blatt B, Chou CL, Fortin AH 6th, Gordon G, Gracey C, Harrell H, Hatem DS, Helmer D, Paterniti DA, Wagner D, Inui TS; Communication, Curriculum, and Culture Study Group. Not the same everywhere. Patient-centered learning environments at nine medical schools. J Gen Intern Med. 2006 May;21(5):405-9.

37.  Havlichek D. Antiviral Agents in: Human Pharmacology: Molecular to Clinical. 4th Edition, 2005

38.  Havlichek D and Stein G. Sulfonamides in: Antimicrobial Therapy and Vaccines, 2nd Edition Yu V, Merigan T, and Barriere S, (ed), 2005

39.  Havlichek DH and Stein GE.  Sulfonamides. In:  Antimicrobial therapy and vaccines.  Volume II:  Antimicrobial Agents.  Second Edition.  ESun technologies, LLC.  Pittsburgh. 2005.

40.  Hoag K, Lillie J, Hoppe R.  Piloting case-based instruction in a didactic clinical immunology course. Clin Lab Sci. 2005 Fall;18(4):213-20.

41.  Holmes-Rovner M, Price C, Rovner DR, Kelly-Blake K, Lillie JA, Wills C, Bonham V. Persistence of men’s theories about BPH and prostate cancer following a decision aid. Jl Gen Intern Med: (2006)21:56-60.

42.  Holmes-Rovner M, Stableford S, Fagerlin A, Wei JR, Dunn RL, Ohene-Frempong J, Kelly-Blake K, Rovner DR. Evidence-based patient choice: a prostate cancer decision aid in plain language BMC Medical Informatics and Decision Making 2005, 5:16-27.

43.  Holmes-Rovner M. Skills for Communicating with Patients: book review. Health Expectations, 2005, 8:277-278.

44.  Holmes-Rovner M. Consequences of increased patient choice. Health Expectations 2005, 8 (1):1-3. 

45.  Holtrop JS, Corser W,  Spence-Jones G, Brooks G, Stommel M, Holmes-Rovner M. Health Behavior Goals of Cardiac Patients After Hospitalization. Amer Jl of Hlth. Behavior, 2006 (Jul-Aug), 30:387-399

46.  Hopkins LM, Davis JM, Buchli R, Vangundy RS, Schwartz KA, Gerlach JA.   MHC class I-associated peptides identified from normal platelets and from individuals with idiopathic thrombocytopenic purpura. Hum Immunol. 2005 Aug;66(8):874-83. Epub 2005 Jul 25.

47.  Hyma KE, Lacher DW, Nelson AM, Bumbaugh AC, Janda JM, Strockbine NA, Young VB, Whittam TS.  Evolutionary genetics of a new pathogenic Escherichia species: Escherichia albertii and related Shigella boydii strains. J Bacteriol. 2005 Jan;187(2):619-28.

48.  Ingersoll K, Ceperich S, Nettleman M, Karanda K, Brocksen S, Johnson BA.  Reducing Alcohol-Exposed Pregnancy Risk in College Women: Initial Outcomes of a Clinical Trial of a Motivational Intervention.  J Subst Abuse Treatment 2005; 29:173-180..

49.  Ishibashi F, Aziz K, Abela GS, Waxman S. Update on Coronary Angioscopy: Review of a 20-Year Experience and Potential Application for Detection of Vulnerable Plaque. Journal of Interventional Cardiology. 19;1-9, 2006.

50.  Kak V.  Morganella species. In:  Antimicrobial therapy and vaccines.  Volume II:  Antimicrobial Agents.  Second Edition.  ESun technologies, LLC.  Pittsburgh. 2005.

51.  Kelly-Blake K, Holmes-Rovner M, Wills CE, Rovner DR, Lillie JA, Price C, Bonham V. Older Men and Sexual Function: Is BPH Treatment a High Stakes Decision? In press, International Journal of Men’s Health.

52.  Khasnis A, Chick D, Havlichek D.  Mycotic Aneurysm of the Tibioperoneal Trunk as a Complication of Aortic Valve Endocarditis Due to Lactobacillus casei Infection: Case Report and Review of Literature.  Infect Dis Clin Pract 2006;14:185–187

53.  Khasnis A, Jongnarangsin K, Abela G, Veerareddy S, Reddy V, Thakur R.  Tachycardia-induced cardiomyopathy:  A Review of the Literature.  PACE 2005;28:1-12.

54.  Khasnis A, Nettleman M. Global warming and infectious diseases.  Archives of Medical Research, 2005; 36(6):689-96

55.  Koleva RI, Conley BA, Romero D, Riley KS, Marto JA, Lux A, Vary CP.  Endoglin structure and function: Determinants of endoglin phosphorylation by TGFbeta receptors. J Biol Chem. 2006 Jun 19; [Epub ahead of print]

56.  Kuehl CJ, Wood HD, Marsh TL, Schmidt TM, Young VB. Colonization of the cecal mucosa by Helicobacter hepaticus impacts the diversity of the indigenous microbiota. Infect Immun. 2005 Oct;73(10):6952-61.

57.  Kumar A, Murray DL, Havlichek DH.  Immunizations for the college student: a campus perspective of an outbreak and national and international considerations. Pediatr Clin North Am. 2005 Feb;52(1):229-41, xi.

58.  Li GY, Xi N, Wang DH. Functionalized nano-robotic end effector for in situ sensing and manipulation of biological specimen. Proceedings of IEEE on Robotics and Automation, 450-455, 2005

59.  Li GY, Xi N, Wang DH. In situ sensing and manipulation of molecules in biological samples using a nano-robotic system. Nanomedicine 1(1):31-40, 2005

60.  Li GY, Xi N, Wang DH. Investigation of angiotensin II type 1 receptor by atomic force microscopy with functionalized tip. Nanomedicine 1(4):306-312, 2005

61.  Li GY, Xi N, Wang DH. Investigation of the type 1 angiotensin II receptor in sensory neuronal cells using the atomic force microscope. Nanomedicine 1(3):255-256, 2005

62.  Li GY, Xi N, Wang DH. Nanotechnology and Membrane Receptors: Focused on Angiotensin II Receptors. Nanomedicine in Medical Clinics, Ed. CM Wei. Elsevier, PA (in press).

63.  Li GY, Xi N, Wang DH. Probing Membrane Proteins Using Atomic Force Microscopy. Journal of Cellular Biochemistry (Invited Prospect) 97:(6);1191-1197, 2006

64.  Li J, Wang DH.  Development of angiotensin II-induced hypertension: role of CGRP and its receptor. J Hypertens. 2005 Jan;23(1):113-8.

65.  Lindner V, Wang Q, Conley BA, Friesel RE, Vary CP.   Vascular injury induces expression of periostin: implications for vascular cell differentiation and migration. Arterioscler Thromb Vasc Biol. 2005 Jan;25(1):77-83. Epub 2004 Oct 28.

66.  Mavis B, Turner J, Lovell K, Wagner D. Faculty, students, and actors as standardized patients: expanding opportunities for performance assessment. Teach Learn Med. 2006 Spring;18(2):130-6.

67.  McKeown NJ, Tews MC, Gossain VV, Shah SM.  Hyperthyroidism. Emerg Med Clin North Am. 2005 Aug;23(3):669-85, viii.

68.  Nettleman M, Ingersoll KS, Ceperich SD.  Characteristics of adult women who abstain from sexual intercourse. J Fam Plann Reprod Health Care. 2006 Jan;32(1):23-4.

69.  Nettleman MD, Ingersoll K, Ceperich SD.  Characteristics of Adult Women Who Abstain from Sexual Intercourse. Journal of Family Planning and Reproductive Health Care (In Press, 2005).

70.  Nettleman MD.  Multidrug-resistant tuberculosis:  News from the front.  JAMA 2005;;293:2788-90.

71.  Nettleman M. Smith SS.  Foreign Travel.  In AAEM Emergency Medical and Family Health Guide.  Emedicine World Library, www.emedicine.com.  2005.

72.  Olomu AB, Watson RE, Siddiqi A, Dwamena FC, McIntosh BA Vasilenko P, Kuppersmith J, Holmes-Rovner MM.  “Study Suggests that Use of Lifesaving Beta-Blockers for Heart Attack Patients is Increasing at Community Hospitals”.  Agency for HealthCare and Research Quality (AHRQ) On-line & Newsletter Publications 2005; # 293.

73.  Pechter E, Davis LK, Tumpowsky C, Flattery J, Harrison R, Reinisch F, Reilly MJ, Rosenman KD, Schill DP, Valiante DV, Filios M.  Work-related Asthma among Health Care Workers:  Surveillance Data from California, Massachusetts, Michigan and New Jersey, 1993-1997.  American Journal of Industrial Medicine 2005; 47:265-275.

74.  Rapp RP, Stein GE, Bosso JA.  Antimicrobial resistance: insights into control and treatment of complicated infections. Pharmacotherapy. 2005 Sep;25(9 Suppl):63S-70S.

75.  Rosenberg B, Juckett DA, Aylsworth CF, Dimitrov NV, Ho S-C, Judge JW, Kessel S, Quensen J, Wong K-P H, Zlatkin I, Zlatkin T.  Protein from Intestinal Eimeria protozoan stimulates IL-12 release from Dendritic Cells, Exhibits Antitumor Properties in vivo and is Correlated with Low Intestinal Tumorigenicity.  Int J Cancer: 2005, 114, 756-765.

76.  Rosenman K, Hertzberg V, Rice C, Reilly MJ, Aronchick J, Parker JE, Regovich J, Rossman M.  Chronic beryllium disease and sensitization at a beryllium processing facility. Environ Health Perspect. 2005 Oct;113(10):1366-72.

77.  Rosenman KD, Kalush A, Reilly MJ, Gardiner JC, Reeves M, Luo Z.  How much work-related injury and illness is missed by the current national surveillance system? J Occup Environ Med. 2006 Apr;48(4):357-65.

78.  Rosenman KD.  Arrhythmias and Sudden Death.  In:  Weeks JL, Levy BS and Wagner GR eds.  Preventing Occupational Disease and Injury.  Washington D.C. 2005; 85-88.

79.  Rosenman KD.  Cleaning Products Related Asthma.  Clinical Pulmonary Medicine 2006; (in press).

80.  Rosenman KD.  Congestive Heart Failure.  In:  Weeks JL, Levy BS and Wagner GR eds.  Preventing Occupational Disease and Injury.  Washington D.C. 2005; 176-177.

81.  Rosenman KD.  Hypertension.  In:  Weeks JL, Levy BS and Wagner GR eds.  Preventing Occupational Disease and Injury.  Washington D.C. 2005; 273-276.

82.  Rosenman KD.  Ischemic Heart Disease.  In:  Weeks JL, Levy BS and Wagner GR eds.  Preventing Occupational Disease and Injury.  Washington D.C. 2005; 290-293.

83.  Rosenman KD.  Occupational Heart Disease. In Rom WN, Markowitz S. eds. Environmental and Occupational Medicine. 4th Edition. Philadelphia: Lippencott-Raven. 2006 (in press).

84.   Rosenman, K, Hertzberg V, Rice C, Reilly MJ, Aronchick J, Parker JE, Regovich J, Rossman M.  Chronic Beryllium Disease and Sensitization at a Beryllium Processing Facility.  Environmental Health Perspectives 2005; 113:1366-1372.      

85.   Rost K, Dickinson M, Dickinson P, Smith RC.  Multisomatoform Disorder:  agreement between patient and physician report of criterion symptom explanation. CNS Spectrums, 2006; in-press.

86.  Ruder AM, Waters MA, Carreón T, Butler MA, Davis-King KE, Calvert GM, Schulte PA, Ward EM, Connally LB, Lu J, Wall D, Zivkovich Z; Heineman EF, Mandel JS, Morton RF, Reding DJ, Rosenman KD, and the Brain Cancer Collaborative Study Group.  Farm and Rural Residence and Other Factors Associated with Primary Intracranial Gliomas: The Upper Midwest Health Study, a Case-Control Study.  Journal of Agricultural Safety and Health 2006; (in press).

87.  Sargent DJ, Conley BA, Allegra C, Collette L.  Clinical trial designs for predictive marker validation in cancer treatment trials. J Clin Oncol. 2005 Mar 20;23:2020-7.

88.  Smith RC, Dwamena FC, Fortin AH 6th.  Teaching personal awareness.  J Gen Intern Med. 2005 Feb;20(2):201-7.

89.  Smith RC, Gardiner JC, Lyles JS, Sirbu C, Dwamena FC, Hodges A, Collins C, Lein C, Given CW, Given B, Goddeeris J.  Exploration of DSM-IV criteria in primary care patients with medically unexplained symptoms. Psychosom Med. 2005 Jan-Feb;67(1):123-9.

90.  Smith RC:  The Difficult Patient.  In:  Rose B, ed, UpToDate (Aronson MD, Fletcher RH, Fletcher SW -- Primary Care Section), 2000; Vol 12, No 2; updated 11/05.

91.  Smith RC, Lyles JS, Gardiner JC, Sirbu C, Hodges A, Collins C, Dwamena FC, Lein C, Given CW, Given B, Goddeers J. Primary Care Clinicians Treat Patients with Medically Unexplained Symptoms – A Randomized Controlled Trial. Journal of General Internal Medicine, 2006;21:671-677.

92.  Solomon, DJ. Strategies for Developing Sustainable Open Access Scholarly Journals. First Monday 2006:11;6

93.  Stein GE and Havlichek DH.  Fosfomycin.  In:  Antimicrobial therapy and vaccines.  Volume II:  Antimicrobial Agents.  Second Edition.  ESun technologies, LLC.  Pittsburgh. 2005.

94.  Stein GE and Havlichek DH.  Nitrofurantoin.  In:  Antimicrobial therapy and vaccines.  Volume II:  Antimicrobial Agents.  Second Edition.  ESun technologies, LLC.  Pittsburgh. 2005.

95.  Stein GE, Goldstein EJ.  Fluoroquinolones and anaerobes. Clin Infect Dis. 2006 Jun 1;42(11):1598-607.

96.  Stein GE, Schooley SL, Peloquin CA, Kak V, Havlichek DH, Citron DM, Tyrrell KL, Goldstein EJ.   Pharmacokinetics and pharmacodynamics of linezolid in obese patients with cellulitis. Ann Pharmacother. 2005 Mar;39(3):427-32. Epub 2005 Feb 8.

97.  Stein GE.  Antimicrobial resistance in the hospital setting: impact, trends, and infection control measures. Pharmacotherapy. 2005 Oct;25(10 Pt 2):44S-54S.

98.  Stein GE.  Safety of newer parenteral antibiotics. Clin Infect Dis. 2005 Sep 1;41 Suppl 5:S293-302.

99.  Tarlo SM, Malo JL and Workshop Members (Rosenman K).  100 Key Questions and Needs in Occupational Asthma.  European Respiratory Journal 2006; (in press).

100.    Tewari A, Horninger W, Pelzer AE, Demers R, Crawford ED, Gamito EJ, Divine G, Johnson CC, Bartsch G, Menon M.  Factors contributing to the racial differences in prostate cancer mortality. BJU Int. 2005 Dec;96(9):1247-52.

101.    Tews MC, Shah SM, Gossain VV.  Hypothyroidism: mimicker of common complaints.Emerg Med Clin North Am. 2005 Aug;23(3):649-67, vii. Review.

102.    Tian W, Wang DH, Cohen DM. Regulation of TRPV1 by a novel renally expressed TRPV1 slice variant. Am J Physiol (Renal Physiology); 290: F117-F126, 2006

103.    Van Waes C, Chang AA, Lebowitz PF, Druzgal CH, Chen Z, Elsayed YA, Sunwoo JB, Rudy SF, Morris JC, Mitchell JB, Camphausen K, Gius D, Adams J, Sausville EA, Conley BA.  Inhibition of nuclear factor-kappaB and target genes during combined therapy with proteasome inhibitor bortezomib and reirradiation in patients with recurrent head-and-neck squamous cell carcinoma. Int J Radiat Oncol Biol Phys. 2005 Dec 1;63(5):1400-12. Epub 2005 Jul 11

104.    Wang DH.  The vanilloid receptor and hypertension. Acta Pharmacol Sin. 2005 Mar;26(3):286-94.

105.    Wang DH. VR1 and salt sensitivity. Act Pharmacol Sin 26(3):286-294, 2005

106.    Wang LH, Chen JZ, Sun YL, Zhang FR, Zhu JH, Hu SJ, Wang DH. HMG-CoA reductase inhibitors reduce connexin40 and connecxin43 expression in rabbit aortic atherosclerosis. Int J Cardiology, 28;100(3):467-475. 2005

107.    Wang LH, Chen JZ, Sun YL, Zhang FR, Zhu JH, Hu SJ, Wang DH. Regulation of connexin expression after balloon injury and statin therapy. Am J of Hypertension 18(9):1146-1153, 2005

108.    Wang LH, Wang DH. Vanilloid receptor gene knockout impairs postischemic recovery in isolated perfused heart in mice. Circulation 112(23):3617-3623, 2005

109.    Wang Y, Chen AF, Wang DH.  ET(A) receptor blockade prevents renal dysfunction in salt-sensitive hypertension induced by sensory denervation. Am J Physiol Heart Circ Physiol. 2005 Nov;289(5):H2005-11.

110.    Wang Y, Kaminski NE, Wang DH.  VR1-mediated depressor effects during high-salt intake: role of anandamide. Hypertension. 2005 Oct;46(4):986-91.

111.    Wang Y, Wang DH.  A Novel Mechanism Contributing to Development of Dahl Salt-Sensitive Hypertension. Role of the Transient Receptor Potential Vanilloid Type 1. Hypertension. 2005 Dec 19; [Epub ahead of print]

112.    Wang YP, Chen AF, Wang DH. Role of ETA receptor in salt sensitive hypertension induced by sensory nerve degeneration. Am J Physiol (Heart & Circulatory Physiology) 289:H2005-H2011, 2005

113.    Wang YP, Kaminski NE, Wang DH. Increased sensitivity of blood pressure to anandamide during high salt intake: role of the VR1 receptor. Hypertension (Featured on the Cover) 46(4):986-991; 2005

114.    Wang YP, Wang DH. A novel mechanism contributing to Dahl salt sensitive hypertension: Role of the TRPV1 channel. Hypertension (Featured on the Cover) 47:3(2);609-614; 2006

115.    Watson RE, Supowit SC, DiPette DJ.  Vasodilator peptides: andrenomedullin, acalcitonin gene-related peptide, and substance-P.  In: Oparil S, Weber MA, eds.  Hypertension: A Companion to Brenner and Rector’s The Kidney.  2nd ed.  Philadelphia: W.B. Saunders Company 2005: 193-202

116.    Wills CE, Holmes-Rovner M. Integrating Decision-Making and Mental Health Intervention Research:  Research Directions. Clinical Psychology. Science and Practice, 2006, 13(1): 9-25.

117.    Wills CE, Holmes-Rovner M, Rovner D, Lillie JA, Kelly-Blake K, Bonham V, Williams G. Treatment Preference Patterns During a Videotape Decision Aid for Benign Prostatic Hyperplasia (BPH). Patient Education and Counseling 2006; 61: 16-22.

118.    Young VB, Kormos WA, Chick DA, Goroll AH.  Blueprints in Medicine, 4th Edition.  Lippencott, Williams and Wilkins, 2006.

119.    Young, VB. and Mansfield LS. (2005) “Campylobacter Infection—Clinical Context” in “Campylobacter: Molecular and Cellular Biology” Julian M. Ketley and Michael E. Konkel editors, Horizon Bioscience, Norfolk, UK pg. 1-12.

120.    Zaroukian MH, Sierra A.  Benefiting from ambulatory EHR implementation: solidarity, six sigma, and willingness to strive. J Healthc Inf Manag. 2006 Winter;20(1):53-60.

121.    Zaroukian MH:  Lymphadenopathy. In: The Complete Patient History – Evidence-based Approach, Tierney Jr. LM, Henderson MC, eds, New York, Lange Medical Books/McGraw-Hill Companies, 2005, pp. 87-95.

122.    Zaroukian MH:  Anxiety. In: The Complete Patient History – Evidence-based Approach, Tierney Jr. LM, Henderson MC, eds, New York, Lange Medical Books/McGraw-Hill Companies, 2005, pp. 549-557.

123.    Zaroukian MH. Electronic Information Management. In: Henderson MC, ed. A Toolkit for Internal Medicine Education Programs, 8th edition, Washington, D.C.: Association of Program Directors in Internal Medicine, 2005, pp. 89-101.

124.    Zaroukian MH. Restoring Confidence in Healthcare – Strategic Priorities in Health Information Technology.  Business Briefing: US Healthcare Strategies, 2005:12-13. www.bbriefings.com/download.cfm?fileID=5620

125.     Zhu Y, Wang Y, Wang DH.  Diuresis and natriuresis caused by activation of VR1-positive sensory nerves in renal pelvis of rats. Hypertension. 2005 Oct;46(4):992-7.

126.     Zhu Y, Wang YP, Wang DH. Natriuresis Caused by Activation of Capsaicin- Sensitive Sensory Nerves in Renal Pelvis of Rats. Hypertension 46(4):992-997;2005


Editorial Boards 2006

 

Faculty Member

Journal

Dr. David Solomon, Editor in Chief

Medical Education Online

Dr. Donna Wang, Editor in Chief

Reviews in CardioEngineering

Dr. David Solomon

BMC Medical Education

Dr. Donna Wang

American Journal of Physiology: Heart and Circulatory Physiology

Dr. Donna Wang

Recent Patent Reviews on Cardiovascular Drug Discovery

Dr. Donna Wang

Nanomedicine

Dr. Donna Wang

Hypertension

Dr. Donna Wang

Current Hypertension Reviews

Dr. Donna Wang

Journal of Cardiothoracic-Renal Research

Dr. Barbara Conley

Molecular Cancer Therapeutics

Dr. Barbara Conley

Clinical Cancer Research

Dr. Gary Ferenchick

MKSAP :Medical Knowledge Self-Assessment Program

Dr. Gary Stein

Issues in Pharmacy

Dr. Mary Nettleman

Emedicine

Dr. Ved Gossain

International Journal of Diabetes in Developing Countries (IJDDC)

 

Study Sections

 

Faculty Member

Study Section

Dr. Donna Wang

Special Emphasis Panel Review, Cardiovascular Sciences Integrated Review Groups (Hypertension and Microcirculation Study Section), Center for Scientific Review, NIH/NHLBI

Dr. Donna Wang

Co-Chair, NIH Study Section, Hypertension & Microcirculation, Center for Scientific Review, NIH/NHLBI

Dr. Donna Wang

NIH/NCRR Study Section, Site Visit to the Research Centers in Minority Institutes Clinical Research Infrastructure Initiative Center, Morehouse School of Medicine, Atlanta, Georgia.

Dr. Donna Wang

NIH Study Section, Special Emphasis Panel Review, Cardiovascular Sciences Integrated Review Groups (Vascular Cell and Molecular Biology Study Section), Center for Scientific Review, NIH/NHLBI

Dr. Donna Wang

NIH/NCRR Study Section, Reverse Site Visit for the Centers of Clinical Research Excellence, Morehouse School of Medicine, Center for Research Resources, NIH/NCRR

Dr. Donna Wang

NIH/NCRR Study Section, RCMI Clinical and Translational Research Network Review, Center for Research Resources, NIH/NCRR

Dr. Barbara Conley

NIH/External Reviewer, CTEP, NCI Concept Review Panel, 2005- present

Dr. Barbara Conley

External Reviewer, National Cancer Research Institute (National Cancer Research Network, UK) Head/Neck Cancer Clinical Studies Group Progress Review, London, England, UK, 2005

Dr. Barbara Conley

Member, American Society for Clinical Oncology Grants Selection Committee: 2003-present

Dr. Kenneth Rosenman

Occupational Health Study Section, National Institute for Occupational Safety and Health           

Dr. Kenneth Rosenman

Agriculture Health and Safety Center Study Section, National Institute for Occupational Safety and Health – Ad hoc member

Dr. Mary Nettleman

CDC: Special Emphasis Panel for Fetal Alcohol Syndrome

Dr. Mary Nettleman

Dept. of Veterans  Affairs:  Research Advisory Committee on Gulf War Illness

Dr. Michael Zaroukian

NIH Study Section, Health of the Population (HOP), Integrated Review Group, Center for Scientific Review, Special Emphasis Panel/Initial Review Group

Dr. Michael Zaroukian

NIH Study Section, Biomedical Information Sciences and Technology Initiative (BISTI), Center for Scientific Review, Special Emphasis Panel/Initial Review Group

Dr. Robert Smith

NIH  Interventions Study Section of the National Institute of Mental Health

 

Awards

 

Faculty Member

Award

Dr. Aron Sousa

Michigan State University Teacher-Scholar Award, 2006

Dr. Barbara Conley

Jack Breslin Professorship, 2005

Dr. Brij Dewan

CHM Outstanding Volunteer Faculty, 2006

Dr. Davoren Chick

Fellow of the American College of Physicians

Dr. Davoren Chick

The Medicine Residency Curriculum authored by Dr. Chick and others was accepted as one of two curriculums declared to be ‘national models’ by the American Program Directors in Internal Medicine society, 2006

Dr. Donna Wang

Chair, Women & Minorities Leadership Committee, American Heart Association National Center

Dr. Donna Wang

Vice President and Board of Directors, Academy of Cardiovascular Research Excellence

Dr. Donna Wang

Keynote speaker at the American Academy of Nanomedicine First Annual Meeting

Dr. Francesca Dwamena

Alpha Omega Alpha

Dr. Gary Ferenchick

Honorable mention at the SBC awards for Instructional Technology for MED 608, the Medicine clerkship, 2006.

Dr. Gary Ferenchick

MSU Nominee:  Glaser Award, American College of Physicians 2006

Dr. Heather Laird-Fick

Outstanding University Faculty Teaching Award, Michigan State Internal Medicine Residency, 2005

Dr. Heather Laird-Fick

Pearl Aldrich Award for Research on Aging, 2006

Dr. Heather Laird-Fick

Teacher-Scholar Award from the College of Human Medicine, 2006


Dr. Jesse Mireles

Gold Humanism Award from the 2006 medical student class

Dr. John Gerlach

HLA subcommittee of the national Clinical and Laboratory Standards Institute, 2006

Dr. John Gerlach

SBC award for Instructional Technology for his fully on-line course, MT 830, 2006

Dr. John Penner

Lifetime Achievement Award from the National Hemophilia Foundation

Dr. John Penner

Jack Breslin Walk for Life Award for Outstanding Contribution to Medicine

Dr. John Penner

Resident Teaching Award, IRMC

Dr. Kevin Kavanagh

CHM Outstanding Community Faculty, 2006

Dr. Mary Nettleman

Ackerman Distinguished Visiting Professor at the University of Arkansas

Dr. Michael Zaroukian

GE Healthcare President’s Award, Centricity HealthCare User Group

Dr. Nik Dimitrov

IRMC Jack Breslin Walk of Life Award

Dr. Nik Dimitrov

NSABP Distinguished Investigator Lifetime Achievement Award

Dr. Ralph Watson

Best Doctors: Information When It Matters Most Best Doctors in America Awards: 2005 and 2006

Dr. Ralph Watson

Board of Directors, Association of Black Cardiologists

Dr. Robert Smith

Laureate of the American College of Physicians by the Michigan Chapter

Dr. Robert Smith

Outstanding University Faculty by the 2006 resident class

Dr. Robert Smith

Mentor Award from CHM, 2006

Dr. Ruth Hoppe

Governor of the Michigan Chapter of the American College of Physicians

Dr. Saleh Aldasouqi

Outstanding Research Faculty by the resident class of 2006

Dr. Ved Gossain

Swartz Professor of Medicine

Dr. Ved Gossain

College of Human Medicine Distinguished Faculty Award

Drs. George Abela, Ralph Watson, Daniel Havlichek, Gary Ferenchick, Ved Gossain

America’s Top Physicians by the Consumer Research Council of America, 2005

 

 

 

 Grants and External Funding

Jan 2005-June 2006

 

Award Amount

PI /

Co-Investigator

Grantor

Title

Board Date

$229,812

YOUNG

CROHNS AND COLITIS FOUNDATION

INTERACTIONS BETWEEN H.HEPATICUS: PROBIOTICS AND OTHER MEMBERS OF THE INTESTINA

6/14/2006

$224,484

WILLIAMS/CONLEY

MICH DEPT OF COMMUNITY HEALTH

KIN KEEPER: CANCER PREVENTION INTERVENTION

6/2/2006

$1,384,867

WHITTAM/ YOUNG

NATL INST OF HEALTH -NIH/PHS

FOOD AND WATERBORNE DISEASES INTEGRATED RESEARCH NETWORK MICROBILOGY RESEARCH UNIT

2/10/2006

$160,378

WATSON

NATL HEART LUNG BLOOD INST -NIH/PHS

ENDOTHELIN ACTIONS ON VASCULAR FUNCTION IN HYPERTENSION

9/16/2005

$291,974

WANG

NATL INST OF HEALTH -NIH/PHS

VANILLOID SENSITIVE SENSORY NERVES AND SALT SENSITIVITY

4/13/2006

$299,000

WANG

NATL INST OF HEALTH -NIH/PHS

VANILLOID SENSITIVE SENSORY NERVES AND SALT SENSITIVITY

4/7/2005

$218,980

WANG

NATL INST OF HEALTH -NIH/PHS

RENAL ANGIOTENSIN II RECEPTOR AND SODIUM INTAKE

4/13/2006

$224,250

WANG

NATL INST OF HEALTH -NIH/PHS

RENAL ANGIOTENSIN II RECEPTOR AND SODIUM INTAKE

4/7/2005

$298,980

WANG

NATL INST OF HEALTH -NIH/PHS

MOLECULAR SENSING OF SODIUM HOMEOSTASIS:  ROLE OF ANANDAMIDE

9/16/2005

$238,550

SOLOMON

HEALTH RESOURCES & SERVICES ADMIN -PHS

TRAINING IN PRIMARY CARE MEDICINE AND DENTISTRY

9/16/2005

$1,667

SCHOLNIK

RHONE POULENC RORER PHARMACEUTICAL INC

RANDOMIZED PHASE 2/3 IN PATIENTS WITH ADVANCED UNTREATED GASTRIC PATIENTS USING TAXOTERE AND CDDP

9/16/2005

$74,330

SCHOLNIK

NATL INST OF HEALTH -NIH/PHS

NSABP MEMBER: MICHIGAN STATE UNIVERSITY

9/16/2005

$3,550

SCHOLNIK

NATL SURGICAL ADJ BRST & BWL PROJ FDN

NSABP FOUNDATION:  TIND 90

4/7/2005

$3,150

SCHOLNIK

NATL SURGICAL ADJ BRST & BWL PROJ FDN

NSABP FOUNDATION:  TIND 90

2/10/2005

$23,880

ROSENMAN

MI COMMUNITY HEALTH

WORK-RELATED ASTHMA EDUCATION PROJECT

4/13/2006

$12,837

ROSENMAN

MI COMMUNITY HEALTH

WORK-RELATED ASTHMA EDUCATION PROJECT

9/16/2005

$20,000

ROSENMAN

MI COMMUNITY HEALTH

WORK-RELATED ASTHMA EDUCATION PROJECT

4/7/2005

$59,000

ROSENMAN

MI COMMUNITY HEALTH

STATE-WIDE ASTHMA MORTALITY REVIEW

4/13/2006

$28,252

ROSENMAN

MI COMMUNITY HEALTH

STATE-WIDE ASTHMA MORTALITY REVIEW

9/16/2005

$50,000

ROSENMAN

MI COMMUNITY HEALTH

STATE-WIDE ASTHMA MORTALITY REVIEW

4/7/2005

$124,000

ROSENMAN

MI CONSUMER AND INDUSTRY SVCS

MICHIGAN SENSOR PROJECT

10/21/2005

$187,500

ROSENMAN

MI CONSUMER AND INDUSTRY SVCS

MICHIGAN SENSOR PROJECT

9/16/2005

$298,557

ROSENMAN

NATL INST OF HEALTH -NIH/PHS

GENETIC EXPOSURE INTERACTION IN BERYLLIUM DISEASE

9/16/2005

$5,400

ROSENMAN

FARM BUREAU INSURANCE

FATALITY ASSESSMENT AND CONTROL EVALUATION (FACE)

4/13/2006

$117,000

ROSENMAN

MI CONSUMER AND INDUSTRY SVCS

FATALITY ASSESSMENT AND CONTROL EVALUATION (FACE)

2/10/2006

$197,947

ROSENMAN

MI CONSUMER AND INDUSTRY SVCS

FATALITY ASSESSMENT AND CONTROL EVALUATION (FACE)

10/21/2005

$97,500

ROSENMAN

MI CONSUMER AND INDUSTRY SVCS

FATALITY ASSESSMENT AND CONTROL EVALUATION (FACE)

9/16/2005

$5,400

ROSENMAN

MICH FARM BUREAU

FATALITY ASSESSMENT AND CONTROL EVALUATION (FACE)

9/16/2005

$140,000

ROSENMAN

OHIO STATE UNIVERSITY

FARM RELATED ASTHMA

2/10/2006

$140,000

ROSENMAN

OHIO STATE UNIVERSITY

FARM RELATED ASTHMA

4/7/2005

$680,242

ROSENMAN

CENTER FOR DISEASE CONTROL -PHS

ENHANCED PROGRAM IN OCCUPATIONAL INJURY AND ILLNESS SURVEILLANCE

9/16/2005

$19,800

ROSENMAN

MI COMMUNITY HEALTH

CORE STATE-BASED SURVEILLANCE

4/7/2005

$21,440

ROSENMAN

CENTER FOR DISEASE CONTROL -PHS

ABLES

10/21/2005

$22,744

ROSENMAN

MI LABOR ECONOMIC GROWTH

ABLES

9/16/2005

$6,500

PRYOR

BLUE CROSS BLUE SHIELD OF MICHIGAN FDTN.

WITHOUT A VISION THE PEOPLE PERISH (WAV) DIABETES INTERVENTION PROGRAM

2/10/2005

$30,000

PRYOR

MARCH OF DIMES FOUNDATION

GENETICS EDUCATION NEEDS EVALUATION (GENE) PROJECT; MICHIGAN DEMONSTRATION PROJECT

4/7/2005

$69,322

PENNER

HEMOPHILIA FOUNDATION OF MICHIGAN I

THROMBOPHILIA GRANT

12/9/2005

$60,064

PENNER

HEMOPHILIA FOUNDATION OF MICHIGAN I

MSU CENTER FOR BLEEDING AND CLOTTING DISORDERS/MCHB

9/16/2005

$103,000

PENNER

HEMOPHILIA FOUNDATION OF MICHIGAN I

MSU CENTER FOR BLEEDING AND CLOTTING DISORDERS/CDC

10/21/2005

$69,000

PENNER

CASCADE HEMOPHILIA CONSORTIUM

HEMOPHILIA TREATMENT CENTER GRANT

10/21/2005

$20,626

PENNER

CASCADE HEMOPHILIA CONSORTIUM

HEMOPHILIA TREATMENT CENTER GRANT

10/21/2005

$19,626

PENNER

CASCADE HEMOPHILIA CONSORTIUM

HEMOPHILIA TREATMENT CENTER GRANT

6/17/2005

$3,000

PENNER

WYETH LABORATORIES

BENEFIX-R STUDY

4/7/2005

$195,825

NOEL/SOUSA

HEALTH RESOURCES & SERVICES ADMIN -PHS

GATEWAY ASSESSMENTS IN UME THROUGH FAMILY PRACTICE

9/16/2005

$91,266

NETTLEMAN

MI COMMUNITY HEALTH

UNDERSTANDING WHY ADULT WOMEN HAVE UNPROTECTED INTERCOURSE WHEN THEY DO NOT DESIRE PREGNANCY

4/7/2005

$104,250

NETTLEMAN

MI COMMUNITY HEALTH

PROJECT UNDERSTAND:  WHY ADULT WOMEN HAVE UNPROTECTED INTERCOURSE AND DON’T DESIRE PREGNANCY

2/10/2006

$5,350

MESSMAN

NATL SURGICAL ADJ BRST & BWL PROJ FDN

NSABP-T IND 090

10/21/2005

$1,000

MACDONALD

ZENECA INC.

RANDOMIZED, DOUBLE BLIND TRIAL COMPARING ARIMIDEX ALONE WITH NOLVADEX ALONE

2/10/2006

$1,000

KULKARNI/ PENNER

HEMOPHILIA/THROMBOSIS RSH SOCIETY

EPIDEMIOLOGY AND TREATMENT OF CIRCULATING ANTICOAGULANTS IN PATIENTS WITH HEMOPHILIA AND VON WILLEBRANDS DISEASE - THE H

9/16/2005

$11,227

KAK

GLAXOSMITHKLIN

MULTI-CENTER STUDY OF THE SAFETY AND EFFICACY OF THREE DAYS CONTINUOUS INTRAVENOUS INFUSION OF GR270773

2/10/2005

$352,944

HOLMES/ ZAROUKIAN

MI COMMUNITY HEALTH

CAPITAL AREA REGIONAL HEALTH INFORMATION ORGANIZATION (CARHIO) PLANNING PROJECT

2/10/2006

$1,700

HAVLICHEK

GLAXOSMITHKLIN

MULTI-CENTER STUDY OF THE SAFETY AND EFFICACY OF THREE DAYS CONTINUOUS INTRAVENOUS INFUSION OF GR270773

9/16/2005

$7,192

HAVLICHEK

PFIZER INC

LINEZOID IN THE TREATMENT OF SUBJECTS WITH COMPLICATED SKIN AND SOFT TISSUE INFECTIONS

12/9/2005

$167,820

GOUDREAU/ STEIN

NATL INST OF HEALTH -NIH/PHS

APOCYNIN NEUROPROTECTION IN A PARKINSONS DISEASE MODEL

4/7/2005

$265

GOSSAIN

LILLY ELI - COMPANY

THE GLOBAL HYPOPITUITARY CONTROL AND COMPLICATIONS STUDY (HYPOCCS)

6/16/2006

$1,020

GOSSAIN

LILLY ELI - COMPANY

GLOBAL HYPO-PITUITARY CONTRLLICATIONS STUDY (HYPOCCS)

10/21/2005

$265

GOSSAIN

LILLY ELI - COMPANY

THE GLOBAL HYPOPITUITARY CONTROL AND COMPLICATIONS STUDY (HYPOCCS)

9/16/2005

$265

GOSSAIN

LILLY ELI - COMPANY

THE GLOBAL HYPOPITUITARY CONTROL AND COMPLICATIONS STUDY (HYPOCCS)

9/16/2005

$795

GOSSAIN

LILLY ELI - COMPANY

THE GLOBAL HYPOPITUITARY CONTROL AND COMPLICATIONS STUDY (HYPOCCS)

4/7/2005

$1,020

GOSSAIN

LILLY ELI - COMPANY

THE GLOBAL HYPOPITUITARY CONTROL AND COMPLICATIONS STUDY (HYPOCCS)

2/10/2005

$350

GOSSAIN

LILLY ELI - COMPANY

THE GLOBAL HYPOPITUITARY CONTROL AND COMPLICATIONS STUDY (HYPOCCS)

2/10/2005

$1,357,647

GOSSAIN

UAW

DIABETES MELLITUS AMONG UAW-GM EMPLOYEES-

2/10/2006

$104,529

GIVEN/ SCHOLNIK

NATL INST OF HEALTH -NIH/PHS

AUTOMATED TELEPHONE MONITORING FOR SYMPTOM MANAGEMENT

9/16/2005

$776,365

GIVEN/ SCHOLNIK

NATL INST OF HEALTH -NIH/PHS

FAMILY HOME CARE FOR CANCER; A COMMUNITY BASED MODEL

6/17/2005

$896,126

GIVEN/ SCHOLNIK

NATL INST OF HEALTH -NIH/PHS

AUTOMATED TELEPHONE MONITORING FOR SYMPTOM MANAGEMENT

6/17/2005

$74,518

CHEATHAM/ ZAROUKIAN

ROBERT WOOD JOHNSON FDN

INFORMATION LINKS: CONNECTING PUBLIC HEALTH WITH HEALTH INVORMATION EXCHANGES

 

$25,000

FERENCHICK

MI UNIV COMM INIT CHALLENGE FUND

JUST-IN-TIME INTERNAL MEDICINE AND JUST-IN-TIME CLINICAL PRACTICE GUIDELINES: RESOURCES FOR HANDHELD COMPUTER

2/10/2006

$2,000

DIMITROV

GLAXO INC

A PROSPECTIVE; RANDOMIZED; MULTICENTRE PHASE III CLINICAL TRIAL...PANOREX INJECTION...

6/16/2006

$53,650

CONLEY

NATL SURGICAL ADJ BRST & BWL PROJ FDN

NSABP-T IND 090

9/16/2005

4075 (variable per pt)

CONLEY

SOUTHWEST ONCOLOGY GROUP (SWOG)

CLINICAL TRIALS RESEARCH

1/10/2006

$2,000

CONLEY

JOHNSON + JOHNSON

A RANDOMIZED CONTROLLED STUDY OF DOCETAXEL MONOTHERAPY OR DOXIL/CAELYZ AND DOCETAXEL FOR THE TREATMENT

9/16/2005

$511,888

ANDERSON/ FERENCHICK

HEALTH & HUMAN SERV US DEPT OF -PHS

FACULTY DEVELOPMENT IN PRIMARY CARE

4/7/2005

$534,556

ANDERSON/ FERENCHICK

HEALTH & HUMAN SERV US DEPT OF -PHS

FACULTY DEVELOPMENT IN PRIMARY CARE

9/16/2005

$5,000

ABELA

A WARD FORD MEMORIAL INSTITUTE

LASER STABLIZATION OF THE VULNERABLE PLAQUE TO PREVENT HEART ATTACKS

2/10/2006

$10,500

ABELA

A WARD FORD MEMORIAL INSTITUTE

LASER STABLIZATION OF THE VULNERABLE PLAQUE TO PREVENT HEART ATTACKS

6/17/2005

$27,000

ABELA

NATL INST OF HEALTH -NIH/PHS

CALCITONIN GENE-RELATED PEPTIDE AND HYPERTENSION

2/10/2006

$27,000

ABELA

NATL INST OF HEALTH -NIH/PHS

CALCITONIN GENE-RELATED PEPTIDE AND HYPERTENSION

4/7/2005